Different strengths – different ISV? [Power / Sample Size]

posted by ElMaestro  – Denmark, 2014-12-21 21:42 (4203 d 22:35 ago) – Posting: # 14129
Views: 9,958

Hi again mittyri,

❝ For exapmle, the formulation 50mg is registered and we're going to conduct the study with the formulation 100 mg.

❝ The drug has linear PK to 120 mg according to the literature.

❝ Could we plan our study with ISV derived from the previous data? Is it safe enough?


A difficult topic. I am aware of people have a theoretical concern about ISV varying with strength but I don't remember ever having seen solid data quantifying the phenomenon.
I think I would just use the ISV from the previous study if that's available.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
170 visitors (0 registered, 170 guests [including 33 identified bots]).
Forum time: 21:17 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5